Covered recipient · General Payments record
EVANGELINE RABARA TREADWELL
Physician Assistants & Advanced Practice Nursing Providers Nurse Anesthetist, Certified Registered
General Payments · PY2021–2024
$1,687.65
- Reported across 110 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $553.02 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $262.62 | 21 |
| QOL Medical, LLC | $115.12 | 6 |
| Takeda Pharmaceuticals U.S.A., Inc. | $112.12 | 5 |
| Janssen Biotech, Inc. | $63.16 | 4 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.55 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051235 | CMS |
| ABBVIE INC. | $15.00 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051237 | CMS |
| ABBVIE INC. | $11.86 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051239 | CMS |
| ABBVIE INC. | $12.45 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051241 | CMS |
| ABBVIE INC. | $9.79 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051243 | CMS |
| ABBVIE INC. | $10.43 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051245 | CMS |
| ABBVIE INC. | $9.61 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051247 | CMS |
| ABBVIE INC. | $13.64 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051249 | CMS |
| ABBVIE INC. | $15.31 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051251 | CMS |
| ABBVIE INC. | $10.25 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051253 | CMS |
| ABBVIE INC. | $10.80 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051255 | CMS |
| ABBVIE INC. | $15.43 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051257 | CMS |
| ABBVIE INC. | $12.08 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051259 | CMS |
| ABBVIE INC. | $11.74 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051261 | CMS |
| ABBVIE INC. | $9.48 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051263 | CMS |
| ABBVIE INC. | $10.99 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051265 | CMS |
| ABBVIE INC. | $12.06 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051267 | CMS |
| ABBVIE INC. | $15.11 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051269 | CMS |
| ABBVIE INC. | $14.92 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051271 | CMS |
| ABBVIE INC. | $10.69 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051273 | CMS |
| ABBVIE INC. | $13.43 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108051275 | CMS |
| Janssen Biotech, Inc. | $13.60 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078725439 | CMS |
| Janssen Biotech, Inc. | $20.64 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078729922 | CMS |
| Janssen Biotech, Inc. | $14.46 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078730610 | CMS |
| Janssen Biotech, Inc. | $14.46 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078726552 | CMS |
| QOL Medical, LLC | $13.67 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147748152 | CMS |
| QOL Medical, LLC | $17.18 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147748154 | CMS |
| QOL Medical, LLC | $20.50 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147748156 | CMS |
| QOL Medical, LLC | $16.61 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147748158 | CMS |
| QOL Medical, LLC | $26.81 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147748160 | CMS |
| QOL Medical, LLC | $20.35 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147748162 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.29 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137811296 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.88 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137811298 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.84 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137811300 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.23 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137811302 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.88 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137811304 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.